For a better understanding of the subject matter disclosed and claimed in the present patent application, the meaning of some terms richly cited in the body of the descriptive report is shown, in which:
The present invention patent of title in the epigraph and subject of description and claim in this application deals with an inventive solution that gives an outstanding benefit to the poultry segment, notably in the sector of poultry reproduction, and more specifically in the stage of application of vaccines and or nutrients in fertile eggs by injection.
In view of the field of application, the applicant, an expert in the area of breeding and development of embryos for breeding of chickens, after detailed studies of the entire classification, vaccination and/or nutrition and hatching techniques, identified a list of emerging needs at the vaccination stage and or nutrition:
In accordance with the demand of the invention the applicant conceived the “IMPROVEMENT APPLIED TO THE FUNCTIONAL MODULE FOR SELECTIVE APPLICATION OF SUBSTANCES INSIDE FERTILE EGGS” provided with novelty associated with inventive activity, since it does not occur in an obvious or evident way from other techniques anticipated by the state of the art, conferring advantages from the industrial, commercial and technical points of view.
In addition, the “invention” is provided with industrial applicability, being economically feasible and thus, considering the accuracy of the patentability requirements, mainly an invention patent, as set forth in the dictates of articles 8 and 13 of Law 9.279.
In order to provide veracity and to consolidate the explicit context in the topics of the introductory table, an explanation will be presented on the state of the art in conventional vaccination modules of fertile eggs, whereby after a critical analysis of these, once evaluated by experts in the subject, can identify its limiting aspects, thus consolidating the identification of the previously cited claim.
a. Architecture of the conventional system: in tight synthesis, selection, vaccination of fertile eggs and dispatch for incubation are carried out by a modular, non-integrated system, that is, the poultry farmer can make use of all or only part of its operational modules, being that for the acculturation, the said conventional system is formed by the following operating modules which are briefly described in the following paragraphs.
a.1 Identification module for fertile eggs: by which, in closed understanding, the operation of selecting fertile eggs can be done with equipment of a manual or automated nature. For equipment of manual nature, the selection operation is done with the aid of a table that emits light under the eggs and the operator visualizes those that allow a greater passage of light classifying them as infertile eggs. In automated systems, there are sensors provided with the emitter and receiver of the light that passes through the eggs. In both situations, a human-machine interface (HMI) management subsystem, or alternatively a handheld equipment having only one table with a light-emitting source is defined, this subsystem acting on the incubation tray, identifying the niches provided with “fertile eggs” and “non-fertile eggs”.
In this way, the procedure of removal of the infertile eggs from the incubation tray takes place, being this operation carried out through a platform with suction cups, and only the “fertile eggs” being kept in the incubation tray”.
a.2 Application module for substances in fertile eggs: where vaccination and or nutrition are performed through injector devices provided with punches and needles for each egg housing niche defined in the incubation tray. From the operational point of view, once the incubation tray is positioned under the vaccination module, the injector array is driven down collectively by moving towards the corresponding incubator tray nodes, where at that time, a computerized system released a vaccine dose (or nutrients) to the needles; and
a.3 Incubation module for fertile eggs: after vaccination of the fertile eggs contained in the incubator tray, these fertile eggs are transferred into a basket, said delivery basket, the transfer being carried out by means of an array of suction cups disposed in a matrix form, which descend simultaneously, where the vacuum is applied both to the suction cups corresponding to the fertile eggs and to the empty housings. The fertile eggs accommodated in the incubator tray are “sucked” by the suction cups, and through a vertical movement, they are transferred to the breeder basket.
b. The paradigm of the invention: once the architecture of the identification system, fertile egg vaccination and incubation of fertile eggs have been presented in general, for the purpose of the present invention has chosen the module of vaccination and/or nutrition of fertile eggs.
Patent database research reveals the prior art vaccination modules, where the following patent documents deserve special mention:
Prior art documents have been shown only for the purpose of prior knowledge that the modules for the application of substances to fertile eggs have long been known, in which the most commonly applied substances are vaccines, and, more recently, the application of nutrients have been considered.
In an allusive way, the constructive concept of the substance application module in fertile eggs is composed of an accommodation and transport device, including a tray in which egg accommodation niches as defined in a matrix form, by which this tray is positioned immediately below the device of multiple injectors of substances, each positioned immediately above its respective egg accommodation niche.
Also, in an allusive way, each injector device has the function of opening the access to the interior of the egg by means of a shell opening mechanism and an injection needle in the most varied configurations possible.
In turn, from the operational point of view, once the niche parity—injector device condition is established, the substance application module is actuated in such a way that simultaneously all the injecting devices are activated, causing the perforation mechanisms of the eggshell, and subsequently the injection needle, which is the carrier element of the substance inside the fertile egg.
In addition to being of significant importance, it should be made clear that the substance to be inoculated with each of the injection needles from each injection device comes from a single source, i.e., a single reservoir, which is released to branches corresponding to each injection device.
c. Critical analysis of the vaccination module and or nutrition: although the current modules for the application of multiple substances into fertile eggs are effective with regard to the procedure of injection of fertile eggs, the careful observation of experts in the area of fertilization and development of poultry embryos identified a list of problems on which should be highlighted:
c.1 From the biosafety point of view: it is explicit the risk of contamination of the injected substance leading to the compromise of the whole stored volume, thus imposing the disposal and sterilization procedure of the entire transport circuit of the substance, from the reservoir to the injection needle;
c.2 From an application level adjustment point of view: where it is explicit that there is only one level of penetration of the needle inside the fertile egg, and no distinction is made on the type of substance being inoculated; and
c.3 from the productivity point of view: the procedure of approximation and contact of the injection device with the fertile eggs, invariably generates some productivity losses by the breaking of eggshell, and the discard of fertilized eggs is being forced.
d. Why do problems occur (cause of effects):
d.1 From the bio-security point of view: can also be explained by the fact that the substance application module is not selective, that is, it does not recognize niches where there is no presence of fertile eggs, due to the process of exclusion of non-fertile eggs carried out in the egg-candling stage, which causes the entire array of injection devices to be triggered, releasing substance even in the area where the niche is empty.
In this scenario, the exposure of the injection needle to the environment becomes evident, which does not occur with the injection needles that effectively inoculated the interior of the eggs.
d.2 From an application level adjustment point of view: it can be explained by the fact that until recently, the substance effectively inoculated was the vaccine, which as a rule, counted on the injection devices originally developed under well-defined inoculation conditions in relation to the amniotic fluid and the embryo itself, and there was no need for control.
However, with the advent of the increasing frequency of practice of nutritional supplementation of fertile eggs, need to control the level of advancement of the injection needle was created, as for this type of nutritional complement, the substance must be poured into the amniotic fluid and not into the embryo's body.
d.3 From the productivity point of view: the cause of the eventual breaks of the eggs after contact of the injection devices can be explained as a result of the constructive concept of the components: head, body and plunger, manufactured on metallic material whose weight contributes to the occurrence of shell break index.
a. Objective: it is an object of the present invention to solve the causes of the problems previously listed in the topic of the fundamentals of the art, by showing an improvement in the application module of substances in the interior of fertile eggs, which adds value in relation to the conventional module, by which in an allusive way this improvement confers the following predicates:
b. Distinctive feature: to make possible the predicates of the improvement in a module of selective application of substances in fertile eggs, an unprecedented system of selective activation of devices of injection of substances has been designed, that is, only the injection devices in which a fertile egg is recognized in the tray niche will be activated.
For this purpose, each substance injection device comprises an individual needle feed module, in the form of a 3/2-way valve which acts in the advanced procedure of its injection needle out of the egg.
In turn, this 3/2-way valve is only activated when the selective injection system of substances identifies the respective tray niche with the fertile egg.
In addition, by looking at a situation when the nutrient administration procedure is a needle feed rate control module, in the form of a feed rate control valve, required for the single procedure of inoculation of the substance into the amniotic fluid, where this speed must be such as to prevent the perforation of the embryo by the needle bevel, in case of incidental contact with its epidermis.
Finally, to meet the goal of minimizing the loss by rupturing the eggshell during the procedure of contacting with the injector, the contact components, notably the head, body and injector piston which are manufactured by 3D forming technology (3d printer) by the process of adding molten ABS filaments, by which this process enables a component which is about 50% lighter.
To complement the present description in order to obtain a better understanding of the features of the present invention, and according to a preferred practical embodiment thereof, the description is accompanied by a set of appended drawings, wherein:
U.S. Pat. No. 6,286,455, showing the main components as well as the logic of its operational drive, evidencing the problem of the collective activation of all injection devices of the device matrix;
The following detailed description should be read and interpreted with reference to the presented drawings, not intended to limit the scope of the invention, this being limited only as explicit in the content of the claims.
a.1 State of the art:
As shown in
The punch (In6) and needle end (In7) components, when in non-operational condition, are collected inside the casing or head (In5);
a.2 Evidenced problem: as shown in
a.3 Cause of the problem: the scenario described above only occurs because of the constructive concept of collective activation of the downward vertical movement of the needles, which is controlled by a collective 5/2-way valve (Va), where a connection (v4) is provided which activates the forward signal of the needles (In7) of each injector (In), and a connection (v2) which activates the needle retraction signal (v2) of each injector (In) of the injector matrix.
b. About the improved substance application module: it has been designed so that the objects of the invention are practicable to actuate the needles only from the injectors (A) having a corresponding fertile egg (Ov) thereon, as shown in
b.1 Base technology (provided in the conventional gun):
b.2: Introduced improvements:
C. The technical effect obtained:
c.1 Selective inoculation of substances: as shown in
c.2 Preservation of the embryo under nutritional supplementation: as shown in
Optimum feed rate (V1) should be ≤35 mm per second.
Only for comparative purposes,
The choice of the preferred embodiment of the invention claimed in this carton, described in this detailed section, is given by way of example only. Any changes, modifications, and variations may be made to any other embodiments of the improved substance application module and corresponding improved injector device (A), which comprises the injector matrix, wherein changes may be designed by those skilled in the art, however without diverging from the object disclosed in the application of the present patent, which is exclusively defined by the annexed claims.
It is seen from what has been described and illustrated that the “IMPROVEMENT APPLIED TO THE FUNCTIONAL MODULE FOR SELECTIVE APPLICATION OF SUBSTANCES INSIDE FERTILE EGGS” heretofore claimed falls within the rules governing the patent in the light of the Industrial Property Law, thus deserving of what has been stated and as a consequence, the respective privilege.
Number | Date | Country | Kind |
---|---|---|---|
BR102015019877-9 | Aug 2015 | BR | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/BR2016/050194 | 8/16/2016 | WO | 00 |